Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166.
N Engl J Med. 2022.
PMID: 36546625
Clinical Trial.
Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan.
Wharton-Smith A, Horter S, Douch E, Gray N, James N, Nyang'wa BT, Singh J, Nusratovna PN, Tigay Z, Kazounis E, Allanazarova G, Stringer B.
Wharton-Smith A, et al. Among authors: kazounis e.
Trials. 2021 Dec 4;22(1):881. doi: 10.1186/s13063-021-05850-0.
Trials. 2021.
PMID: 34863253
Free PMC article.
Clinical Trial.
Item in Clipboard
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Berry C, du Cros P, Fielding K, Gajewski S, Kazounis E, McHugh TD, Merle C, Motta I, Moore DAJ, Nyang'wa BT.
Berry C, et al. Among authors: kazounis e.
Trials. 2022 Jun 13;23(1):484. doi: 10.1186/s13063-022-06331-8.
Trials. 2022.
PMID: 35698158
Free PMC article.
Item in Clipboard
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
Sweeney S, Berry C, Kazounis E, Motta I, Vassall A, Dodd M, Fielding K, Nyang'wa BT.
Sweeney S, et al. Among authors: kazounis e.
PLOS Glob Public Health. 2022 Dec 7;2(12):e0001337. doi: 10.1371/journal.pgph.0001337. eCollection 2022.
PLOS Glob Public Health. 2022.
PMID: 36962909
Free PMC article.
Item in Clipboard
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL team.
Nyang'wa BT, et al. Among authors: kazounis e.
Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16.
Lancet Respir Med. 2024.
PMID: 37980911
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite